Super resolution label-free imaging in highly scattering bone
Super resolution label-free imaging in highly scattering bone
批准号:
9921367
负责人:
Luke J. Mortensen
金额:
$17.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2022-01-31
关键词:
3-DimensionalBiological AssayBiological MonitoringBone DiseasesBone TissueCaliberCartilageCell Differentiation processCell TherapyCellsChildhoodClinicalCollagenCrystallizationDefectDepositionDevelopmentDevicesDiseaseFiberFlow CytometryGenerationsGrowthHealthHumanHydroxyapatitesHypophosphatasiaImageImmunosuppressionIn VitroIndustryKineticsKnowledgeLabelLasersMammalsMeasuresMembraneMembrane LipidsMesenchymal Stem Cell TransplantationMesenchymal Stem CellsMetabolic Bone DiseasesMicroscopyMineralsModalityMonitorMultivesicular BodyMusOsteoblastsOsteogenesisOsteogenesis ImperfectaOsteoporosisOutcomePathway interactionsProcessProductionPropertyProtocols documentationRefractive IndicesResearchResolutionRoleScanningScientific Advances and AccomplishmentsSourceStem cell transplantSurfaceTechnologyTherapeuticTimeTissuesVesicleWorkbasebioprocessbonecell behaviordigitalimage reconstructionimaging modalityimprovedin vivomesenchymal stromal cellmultiphoton microscopynanometernanoscalenovel imaging technologyoptical imagingosteogenicparacrinesecond harmonicstem cell differentiationthree-dimensional visualizationtransplant modelvesicular release
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Mesenchymal stem cells (otherwise known as mesenchymal stromal cells or MSCs) hold great promise for
treatment of bone related disorders due to their paracrine, multi-potential and immunosuppressive effects. One
major objective is to leverage the osteogenic differentiation of MSCs as potential treatments in metabolic bone
disorders (e.g. osteoporosis, osteogenesis imperfecta, or hypophosphatasia) or localized bone defects.
However, knowledge of the MSC differentiation control pathways and how to leverage these during
bioprocessing is lacking and has impeded more widespread clinical translation1-3. Unfortunately, the current
clinical and industry state-of-the-art for characterization of MSC potency is to simply measure a few surface
markers using flow cytometry and to study the ability of cells to differentiate in vitro into the target tissues (e.g.
bone/cartilage). These assays are challenging to quantify, slow to perform, and have low direct relevance to in
vivo functioning4. Our proposal aims to leverage development of novel imaging technologies to identify
in vivo processes of key significance to transplanted stem cell differentiation and healthy bone tissue
production, and will interrogate and leverage membrane lipid pathways to maintain and enhance the
differentiation potential of MSCs.
Our planned research is motivated by growing appreciation of how lipid membrane processing
regulates cellular properties of central regulatory importance in bone formation, where maturing osteoblasts
produce and secrete mineralizing matrix vesicles in multivesicular bodies of ~500 nanometer diameter that
nucleate the deposition and growth of hydroxyapatite mineral crystals in bone collagen5,6. Little is known about
processes that drive the formation and secretion of these vesicles, which is a pathway of central importance in
the formation of mature cartilage and bone. This formation process is challenging to label, but with a high
refractive index change it is ideal for refractive index sensitive modalities like third harmonic generation
imaging. In this work, we hypothesize that 3-dimensional time-resolved super resolution membrane
imaging will provide a direct readout of vesicle formation profiles that will predict cell differentiation
and potency. In these studies, we will develop ultra-resolution multiphoton microscopy to monitor MSC
collagen production and mineralizing vesicle release during osteogenic differentiation. We will then apply this
technology in vivo using adaptive scattering wavefront correction for intravital super-resolution third harmonic
generation microscopy to monitor MSC matrix vesicle formation and produce high potency osteogenic cells.
This will significantly advance scientific understanding from a technological perspective by enabling the label-
free super-resolution 3-dimensional visualization of nanometer-sized features through completely opaque
highly scattering bone tissue. We have the potential to transform treatment of bone diseases, with results that
would be broadly applicable to a range of human health concerns.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金